Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Oligodendroglioma 1Familial ependymoma 1Central Nervous System Neoplasms 1Astrocytoma 1

Interventions

Temozolomide 15Radiotherapy 12Lomustine 5Carboplatin 5Vincristine 4Carmustine 4Granulocyte Colony-Stimulating Factor 3Filgrastim 3Etoposide 3Chemotherapy, Adjuvant 3lonafarnib 2imetelstat 2etoposide phosphate 2Thiotepa 2Radiotherapy, Intensity-Modulated 2Radiotherapy, Conformal 2Radiation 2Psychiatric Rehabilitation 2Procarbazine 2Peripheral Blood Stem Cell Transplantation 2Magnetic Resonance Spectroscopy 2Irinotecan 2Drug Therapy 2vorasidenib 1veliparib 1transforming growth factor(alpha)-Pseudomonas aeruginosa exotoxin (38) 1selinexor 1sargramostim 1palbociclib 1laromustine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Astrocytoma × transforming growth factor(alpha)-Pseudomonas aeruginosa exotoxin (38) × Clear all
NCT00074334 2009-10-21

TP-38 Toxin in Treating Young Patients With Recurrent or Progressive Supratentorial High-Grade Glioma

Pediatric Brain Tumor Consortium

Phase 1/2 Terminated
3 enrolled
CNS

Familial ependymoma, Astrocytoma, Oligodendroglioma, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡